methamphetamine and Parkinsonian Disorders

methamphetamine has been researched along with Parkinsonian Disorders in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (60.87)29.6817
2010's9 (39.13)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, K; Inoue, R; Kawai, K; Nishime, C; Nishinaka, E; Tsutsumi, H; Urano, K1
Gupta, SP; Mishra, SK; Singh, MP; Singhal, NK; Tiwari, MN; Yadav, S1
Dagda, RK; Das Banerjee, T; Janda, E1
Hisahara, S; Honmou, O; Iwahara, N; Kawamata, J; Matsumura, A; Matsushita, T; Sasaki, M; Shimohama, S; Suzuki, S1
Grill, WM; McConnell, GC; So, RQ2
Asanuma, M; Miyazaki, I1
Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H1
Biagioni, F; Fornai, F; Fulceri, F; Murri, L; Paparelli, A; Ruggieri, S1
Rusyniak, DE1
August, AT; Grill, WM; McConnell, GC; So, RQ1
Asakawa, T; Ito-Yamashita, T; Namba, H; Sugiyama, K; Sun, W1
Alessandrí, MG; Fornai, F; Geppert, M; Jahn, R; Schlüter, OM; Südhof, TC; Takamori, S1
Aiken, SS; Ang, L; Fitzmaurice, P; Kalasinsky, KS; Kish, SJ; Moszczynska, A; Peretti, FJ; Schmunk, GA; Wickham, DJ1
Bannai, M; Kondoh, T; Nishino, H; Torii, K1
Hayashi, K; Inden, M; Inoue, K; Kim, DH; Kitamura, Y; Nishimura, K; Qi, M; Shimohama, S; Sumi, S; Takata, K; Taniguchi, T; Tsuchiya, D; Yanagisawa, D; Yoshimoto, K1
Ando, K; Higuchi, M; Inaji, M; Maeda, J; Nagai, Y; Nariai, T; Obayashi, S; Ohno, K; Okano, H; Okauchi, T; Suhara, T; Yoshizaki, T1
Dluzen, DE; Liu, B1
Bandettini Di Poggio, A; De Blasi, A; Fornai, F; Lazzeri, G; Nicoletti, F; Paparelli, A; Ruggieri, S; Soldani, P1
Bell, KP; Choi, PK; Clarkson, ED; Esplen, JE; Freed, CR; Heidenreich, KA; Zawada, WM1
Cadet, JL1
Anderson, LI; Dluzen, DE; Kucera, J; McDermott, JL; Walro, JM1
Hashiguchi, H; Ishida, Y; Mitsuyama, Y; Nishimori, T; Takeda, R; Todaka, K1

Reviews

6 review(s) available for methamphetamine and Parkinsonian Disorders

ArticleYear
Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?
    Molecular neurobiology, 2014, Volume: 49, Issue:1

    Topics: Animals; Humans; Methamphetamine; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Parkinsonian Disorders; Reactive Nitrogen Species; Rotenone

2014
How Parkinsonian toxins dysregulate the autophagy machinery.
    International journal of molecular sciences, 2013, Nov-08, Volume: 14, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Autophagy; Humans; Methamphetamine; Mitophagy; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rotenone

2013
Approaches to prevent dopamine quinone-induced neurotoxicity.
    Neurochemical research, 2009, Volume: 34, Issue:4

    Topics: Animals; Dopamine; Humans; Methamphetamine; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders

2009
Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.
    International review of neurobiology, 2009, Volume: 88

    Topics: Amphetamine-Related Disorders; Animals; Brain; Dopamine; Humans; Levodopa; Methamphetamine; Parkinsonian Disorders; Receptors, Dopamine D1; Signal Transduction

2009
Neurologic manifestations of chronic methamphetamine abuse.
    Neurologic clinics, 2011, Volume: 29, Issue:3

    Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinsonian Disorders

2011
Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice.
    Parkinsonism & related disorders, 2001, Volume: 8, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methamphetamine; Mice; Mice, Knockout; Mice, Transgenic; Neurotoxins; Oxidopamine; Parkinsonian Disorders

2001

Other Studies

17 other study(ies) available for methamphetamine and Parkinsonian Disorders

ArticleYear
Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine.
    Behavioural pharmacology, 2017, Volume: 28, Issue:8

    Topics: Animals; Apomorphine; Area Under Curve; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Immunohistochemistry; Levodopa; Male; Methamphetamine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase

2017
Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Neuroscience letters, 2015, Jan-01, Volume: 584

    Topics: Animals; Dopaminergic Neurons; Female; Humans; Mesenchymal Stem Cell Transplantation; Methamphetamine; Nerve Degeneration; Neuroglia; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase

2015
Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
    Journal of neurophysiology, 2016, 06-01, Volume: 115, Issue:6

    Topics: Action Potentials; Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Haloperidol; Implantable Neurostimulators; Methamphetamine; Microelectrodes; Neural Inhibition; Neurons; Oxidopamine; Parkinsonian Disorders; Pars Reticulata; Rats, Long-Evans; Subthalamic Nucleus

2016
Frequency-dependent, transient effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling and neuronal activity in the hemiparkinsonian rat.
    Behavioural brain research, 2017, 03-01, Volume: 320

    Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Disease Models, Animal; Dose-Response Relationship, Radiation; Linear Models; Male; Methamphetamine; Neurons; Parkinsonian Disorders; Rats; Rats, Long-Evans; Subthalamic Nucleus; Time Factors

2017
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
    Neuroscience research, 2008, Volume: 62, Issue:4

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase

2008
Characterizing effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling behavior in hemi-Parkinsonian rats.
    IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society, 2012, Volume: 20, Issue:5

    Topics: Animals; Behavior, Animal; Deep Brain Stimulation; Mental Disorders; Methamphetamine; Parkinsonian Disorders; Rats; Rats, Long-Evans; Subthalamic Nucleus; Treatment Outcome

2012
Behavioral performance at early (4 weeks) and later (6 months) stages in rats with unilateral medial forebrain bundle and striatal 6-hydroxydopamine lesions.
    Neurologia medico-chirurgica, 2013, Volume: 53, Issue:1

    Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Corpus Striatum; Injections; Male; Medial Forebrain Bundle; Methamphetamine; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior

2013
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Neuroscience, 2003, Volume: 118, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; alpha-Synuclein; Animals; Antibodies; Blastomeres; Blotting, Southern; Corpus Striatum; Disease Models, Animal; DNA Primers; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Homovanillic Acid; Humans; Immunoblotting; Immunohistochemistry; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Piperazines; Rats; Reserpine; Serotonin; Stem Cells; Subcellular Fractions; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase

2003
Why is parkinsonism not a feature of human methamphetamine users?
    Brain : a journal of neurology, 2004, Volume: 127, Issue:Pt 2

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Cause of Death; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Female; Humans; Male; Methamphetamine; Parkinsonian Disorders; Putamen

2004
6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Experimental neurology, 2005, Volume: 192, Issue:1

    Topics: Animals; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methamphetamine; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Predictive Value of Tests; Rats; Rats, Wistar; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase

2005
Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
    Neuroscience letters, 2005, Oct-28, Volume: 387, Issue:3

    Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Tissue Transplantation; Cell Count; Corpus Striatum; Denervation; Disease Models, Animal; Graft Survival; Growth Cones; Hyperkinesis; Male; Methamphetamine; Mice; Neurons; Oxidopamine; Parkinsonian Disorders; Pluripotent Stem Cells; Rats; Rats, Wistar; Recovery of Function; Stem Cell Transplantation; Substantia Nigra; Subthalamic Nucleus

2005
Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.
    Brain research, 2005, Dec-07, Volume: 1064, Issue:1-2

    Topics: Animals; Apomorphine; Autoradiography; Behavior, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Functional Laterality; Male; Methamphetamine; Movement; Neostriatum; Neurons; Oxidopamine; Parkinsonian Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2

2005
Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Synapse (New York, N.Y.), 2006, Volume: 60, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogens; Female; Male; Methamphetamine; Mice; Nerve Degeneration; Neural Pathways; Neuroprotective Agents; Neurotoxins; Orchiectomy; Ovariectomy; Parkinsonian Disorders; Substantia Nigra

2006
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
    Annals of the New York Academy of Sciences, 2006, Volume: 1074

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Methamphetamine; Neurotoxins; Parkinsonian Disorders; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Substantia Nigra; Ubiquitin

2006
IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands.
    Experimental neurology, 2001, Volume: 168, Issue:1

    Topics: Abortion, Induced; Animals; Apomorphine; Brain; Brain Tissue Transplantation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dopamine; Female; Fetal Tissue Transplantation; Fibroblast Growth Factor 2; Homovanillic Acid; Humans; Insulin-Like Growth Factor I; Male; Methamphetamine; Motor Activity; Neurons; Oxidopamine; Parkinsonian Disorders; Pregnancy; Rats; Rats, Sprague-Dawley; Rotation; Transplantation, Heterologous; Tyrosine 3-Monooxygenase

2001
Striatal dopamine output is compromised within +/- BDNF mice.
    Synapse (New York, N.Y.), 2002, Volume: 43, Issue:2

    Topics: Animals; Brain-Derived Neurotrophic Factor; Dopamine; Drug Interactions; Extracellular Space; Female; Genotype; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Mice, Knockout; Neostriatum; Neural Pathways; Neurons; Parkinsonian Disorders; Perfusion; Potassium; Substantia Nigra

2002
Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neurons.
    Brain research, 2002, Jun-14, Volume: 940, Issue:1-2

    Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cell Differentiation; Disease Models, Animal; Female; Fetal Tissue Transplantation; Graft Survival; Immunohistochemistry; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase

2002